Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Bio-X-Cell Research

Neither a doctor nor a teaching hospital

Research payments

$88,936

19 payments

Through program year 2025, Bio-X-Cell Research is reported as receiving $88,936 in research payments, across 19 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $46,470 5
2024 Research $6,379 5
2022 Research $36,087 9

Breakdown

Who paid Research payments · program years 2022–2025
  1. Organogenesis Inc. $46,470 5 payments
  2. Endo Pharmaceuticals Inc. $36,087 9 payments
  3. TissueTech, Inc. $6,379 5 payments
Studies the money was for Research payments · program years 2022–2025
  1. PREPARE PuraPly AM/XT $46,470 5 payments
  2. A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis $36,087 9 payments
  3. Ttax01-Cr003 $6,379 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record